Evaluation of outcomes associated with antipseudomonal beta-lactams for treatment of methicillin-susceptible <i>Staphylococcus aureus</i> bacteremia: a retrospective cohort analysis
No differences in mortality or bacteremia recurrence were identified among patients with MSSA bacteremia treated with APBLs compared to SOC. Larger studies should be performed to confirm these findings.
Authors
- Margaret Fielding
- Vidhu Kariyawasam (ORCID: https://orcid.org/0000-0003-3895-5673)
- Barbara A. Santevecchi (ORCID: https://orcid.org/0000-0001-5239-8303)
- Kalen B. Manasco
- Veena Venugopalan (ORCID: https://orcid.org/0000-0002-9424-5783)
- Kathryn DeSear (ORCID: https://orcid.org/0000-0002-9042-9075)
- Lisa Vuong
Institutions
- UF Health Shands Hospital (US)
- American Association of Colleges of Pharmacy (US)
- University of Florida Health (US)
- University of Florida (US)
- University of Florida Health Science Center (US)
- Florida College (US)
Publication Details
- Journal
- Therapeutic Advances in Infectious Disease
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1177/20499361251395527
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00